ROIV Roivant Sciences Ltd. | BMG762791017
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 25.181.655.040 | 19.953.761.641,79 | 15.400.260.760,15 | 10.435.121.287,03 |
| Enterprise Value | 21.762.304.000 | 18.641.967.641,79 | 14.030.929.760,15 | 9.296.957.287,03 |
| Trailing P/E | - | - | - | - |
| Forward P/E | -22,45 | - | - | - |
| Price to Sales | 3.048,63 | 2.415,71 | 1.157,04 | 922,56 |
| Price to Book | 5,57 | 4,41 | 3,61 | 2,39 |
| EV/Revenue | 2.634,66 | 2.256,9 | 1.054,16 | 821,94 |
| EV/EBITDA | -17,05 | - | - | - |